深度分析批次二 — 跨国标的
第二批深度扫描：欧洲、亚洲及特殊主题标的
扫描范围
覆盖欧洲银行、亚洲消费、能源/金属等特殊主题标的。数据来源：yfinance + SEC EDGAR + 分析师共识。
重点标的
| 代码 | 公司 | 价格 | Fwd PE | PB | 股息率 | ROE | 估值判断 |
|---|---|---|---|---|---|---|---|
| ACN | Accenture | $179 | 12.0x | 4.8 | 1.50% | 29% | 🟢 低估 |
| ADBE | Adobe | $245 | 9.3x | 8.5 | — | 59% | 🟢 低估 |
| CB | Chubb | $328 | 11.2x | 1.3 | — | 15% | 🟢 低估 |
| GSK | GSK plc | $51 | 9.8x | 4.5 | 3.50% | 41% | 🟢 低估 |
| CI | Cigna | $286 | 8.5x | 1.8 | 2.18% | 16% | 🟢 低估 |
| NEM | Newmont | $108 | 9.4x | 2.2 | — | 26% | 🟢 低估 |
| ING | ING Group | $31 | 9.7x | 1.0 | — | 17% | 🟢 低估 |
| BCS | Barclays | $24 | 7.0x | 0.5 | — | — | 🟢 破净 |
| HCA | HCA Healthcare | $394 | 11.9x | — | — | — | 🟡 合理偏低 |
| BTI | BAT Industries | $65 | 12.3x | 1.6 | 5.80% | — | 🟡 合理 |
综合观察
- 最便宜: BCS (7.0x PE, 破净), PDD (6.67x PE), CMCSA (6.61x PE)
- 最稳健: GSK (ROE 41%, 3.5% 股息), ING (ROE 17%, 破净)
- 最有弹性: ADBE (9.3x PE + 59% ROE, Firefly AI 催化), ACN (12x PE, AI 咨询需求)
- 需注意: PFE (分红覆盖不住), CMCSA (利润下滑), BCS/ING/BNP (外国ADR无SEC filing)